US Patent 7338667 Pharmaceutical formulation
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erasable hydrophilic polymeric matrix.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07338667 Pharmaceutical formulation US Patent 7338667 Pharmaceutical formulation
Infobox
Patent Number
0733866700
Patent Number
733866700
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073386670
Date of Patent
March 4, 2008
0Patent Application Number
103422220
Date Filed
January 15, 2003
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073386670
Date of Patent
March 4, 2008
0Patent Application Number
103422220
Date Filed
January 15, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07338667 Pharmaceutical formulation
Infobox
Is a
Patent jurisdiction
Patent number
07338667
Date of patent
March 4, 2008
Patent application number
10342222
Date Filed
January 15, 2003
Patent primary examiner
Find more entities like US Patent 7338667 Pharmaceutical formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.